MedPath

Evaluation of the effectiveness of neurofeedback on irritable bowel syndrome

Not Applicable
Conditions
Irritable Bowel Syndrom.
Irritable bowel syndrome
Registration Number
IRCT20191215045743N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Having diagnostic criteria for IBS based on Rome III criteria , all three types of IBS included: C, D and M kind
age between 18 and 45 years
education: at least second level at middle school degree

Exclusion Criteria

patients who refused to participate in study
positive Family history of colon cancer
WBC, parasites and blood in the stool
History of thyroid disorders and abnormal thyroid test,
Patients with unstable weight loss, anemia and eosinophilia, rectosigmoid and abnormal scoping
Having diagnostic Criteria of Severe psychiatric and neurological disorders based on psychiatrist diagnosis.
Having bloody stools

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of gastrointestinal symptoms of irritable bowel syndrome based on IBS Symptom Severity Questionnaire,Symptoms of depression, anxiety and stress based on the score in DASS-42,Quality of life based on score in IBS-QOL-34 questionnaire. Timepoint: Before the intervention, the severity of gastrointestinal symptoms, depression, anxiety, stress and quality of life are measured. The list of alpha and beta waves is saved after each session. At the end of the sessions, the rate of gastrointestinal symptoms, psychological symptoms and quality of life are measured. Method of measurement: IBS-SSS Intensity of Gastrointestinal Symptoms Questionnaire, DASS-42 Questionnaire - Quality of Life Assessment QOL-34. Record brain waves of alpha and beta waves.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath